TABLE 3.
Incidence and severity of recurrent genital herpes in guinea pigs treated with P-4010 or given placebo during primary HSV-2 infection
Expt no. | No. of animals in recurrent phase | Treatment during primary infection | Total no. of lesions | Mean total lesion score/guinea pig
|
Mean no. of days on which lesions observed
|
Lesion score of ≥3
|
Index of recurrent disease severitya | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
% of guinea pigs | Mean no. of days
|
||||||||||
No. | % Redb | No. | % Red | No. | % Red | ||||||
5 | 18 | P-4010 | 823 | 48.4 | 42 | 27.2 | 12 | 94 | 5.3c | 48 | 1.78 |
18 | Placebo | 1,302 | 69.3 | 31.0 | 100 | 10.2 | 2.24 | ||||
7 | 26 | P-4010 | 543 | 17.5c | 30 | 10.9c | 20 | 61 | 1.6c | 64 | 1.61 |
26 | Placebo | 912 | 30.4 | 13.6 | 77 | 43 | 2.24 |
Ratio of mean total lesion score per guinea pig to mean number of days on which lesions were observed.
% Red, percent reduction from control (placebo).
Significantly lower than the control (placebo) value.